APO Research
Talk to an analyst

APO RESEARCH · REPORT

OAB Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OAB Treatment Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchOAB Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal OAB Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal OAB Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OAB Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal OAB Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global OAB Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for OAB Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OAB Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OAB Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OAB Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of OAB Treatment include Astellas Pharma, Kyorin Pharmaceutical, AbbVie, Pfizer, Johnson & Johnson and Teva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for OAB Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OAB Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for OAB Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OAB Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OAB Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for OAB Treatment revenue, projected growth trends, production technology, application and end-user industry.

OAB Treatment Segment by Company

Astellas Pharma

Kyorin Pharmaceutical

AbbVie

Pfizer

Johnson & Johnson

Teva

OAB Treatment Segment by Type

Botox

Mirabegron

Anticholinergics

Others

OAB Treatment Segment by Application

Idiopathic Overactive Bladder

Neurogenic Overactive Bladder

OAB Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OAB Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OAB Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OAB Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of OAB Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of OAB Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OAB Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OAB Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Botox Major Player Table 3. Mirabegron Major Player Table 4. Anticholinergics Major Player Table 5. Others Major Player Table 6. Global OAB Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Idiopathic Overactive Bladder Major Player Table 8. Neurogenic Overactive Bladder Major Player Table 9. OAB Treatment Industry Trends Table 10. OAB Treatment Industry Drivers Table 11. OAB Treatment Industry Opportunities and Challenges Table 12. OAB Treatment Industry Restraints Table 13. Global OAB Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global OAB Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global OAB Treatment Market Share by Region (2021-2026) Table 16. Global OAB Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global OAB Treatment Market Share by Region (2027-2032) Table 18. Global OAB Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global OAB Treatment Revenue Market Share by Players (2021-2026) Table 20. Global OAB Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global OAB Treatment Key Players Headquarters & Area Served Table 22. Global OAB Treatment Players, Product Type & Application Table 23. Global OAB Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global OAB Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global OAB Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global OAB Treatment Revenue Market Share by Type (2021-2026) Table 30. Global OAB Treatment Revenue Market Share by Type (2027-2032) Table 31. Global OAB Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global OAB Treatment Revenue Market Share by Application (2021-2026) Table 35. Global OAB Treatment Revenue Market Share by Application (2027-2032) Table 36. Astellas Pharma Company Information Table 37. Astellas Pharma Business Overview Table 38. Astellas Pharma OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Astellas Pharma OAB Treatment Product Portfolio Table 40. Astellas Pharma Recent Development Table 41. Kyorin Pharmaceutical Company Information Table 42. Kyorin Pharmaceutical Business Overview Table 43. Kyorin Pharmaceutical OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Kyorin Pharmaceutical OAB Treatment Product Portfolio Table 45. Kyorin Pharmaceutical Recent Development Table 46. AbbVie Company Information Table 47. AbbVie Business Overview Table 48. AbbVie OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. AbbVie OAB Treatment Product Portfolio Table 50. AbbVie Recent Development Table 51. Pfizer Company Information Table 52. Pfizer Business Overview Table 53. Pfizer OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pfizer OAB Treatment Product Portfolio Table 55. Pfizer Recent Development Table 56. Johnson & Johnson Company Information Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Johnson & Johnson OAB Treatment Product Portfolio Table 60. Johnson & Johnson Recent Development Table 61. Teva Company Information Table 62. Teva Business Overview Table 63. Teva OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Teva OAB Treatment Product Portfolio Table 65. Teva Recent Development Table 66. North America OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 67. North America OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 68. North America OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 69. North America OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 70. North America OAB Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America OAB Treatment Revenue by Country (2021-2026) & (US$ Million) Table 72. North America OAB Treatment Revenue by Country (US$ Million) & (2027-2032) Table 73. Europe OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 74. Europe OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 75. Europe OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 76. Europe OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 77. Europe OAB Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe OAB Treatment Revenue by Country (2021-2026) & (US$ Million) Table 79. Europe OAB Treatment Revenue by Country (US$ Million) & (2027-2032) Table 80. China OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 81. China OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 82. China OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 83. China OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 85. Asia OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 86. Asia OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 87. Asia OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia OAB Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia OAB Treatment Revenue by Region (US$ Million) & (2021-2026) Table 90. Asia OAB Treatment Revenue by Region (US$ Million) & (2027-2032) Table 91. SAMEA OAB Treatment Revenue by Type (2021-2026) & (US$ Million) Table 92. SAMEA OAB Treatment Revenue by Type (2027-2032) & (US$ Million) Table 93. SAMEA OAB Treatment Revenue by Application (2021-2026) & (US$ Million) Table 94. SAMEA OAB Treatment Revenue by Application (2027-2032) & (US$ Million) Table 95. SAMEA OAB Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. SAMEA OAB Treatment Revenue by Country (2021-2026) & (US$ Million) Table 97. SAMEA OAB Treatment Revenue by Country (US$ Million) & (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. OAB Treatment Image Figure 2. Global OAB Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OAB Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Botox Image Figure 5. Mirabegron Image Figure 6. Anticholinergics Image Figure 7. Others Image Figure 8. Global OAB Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global OAB Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. Idiopathic Overactive Bladder Image Figure 11. Neurogenic Overactive Bladder Image Figure 12. Global OAB Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global OAB Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global OAB Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global OAB Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global OAB Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global OAB Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global OAB Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global OAB Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global OAB Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global OAB Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America OAB Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America OAB Treatment Revenue Share by Type (2021-2032) Figure 25. North America OAB Treatment Revenue Share by Application (2021-2032) Figure 26. North America OAB Treatment Revenue Share by Country (2021-2032) Figure 27. United States OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe OAB Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe OAB Treatment Revenue Share by Type (2021-2032) Figure 32. Europe OAB Treatment Revenue Share by Application (2021-2032) Figure 33. Europe OAB Treatment Revenue Share by Country (2021-2032) Figure 34. Germany OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China OAB Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China OAB Treatment Revenue Share by Type (2021-2032) Figure 44. China OAB Treatment Revenue Share by Application (2021-2032) Figure 45. Asia OAB Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia OAB Treatment Revenue Share by Type (2021-2032) Figure 47. Asia OAB Treatment Revenue Share by Application (2021-2032) Figure 48. Asia OAB Treatment Revenue Share by Region (2021-2032) Figure 49. Japan OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA OAB Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA OAB Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA OAB Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA OAB Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt OAB Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Botox
  • Mirabegron
  • Anticholinergics
  • Others
Applications
  • Idiopathic Overactive Bladder
  • Neurogenic Overactive Bladder
Companies covered
  • Astellas Pharma
  • Kyorin Pharmaceutical
  • AbbVie
  • Pfizer
  • Johnson & Johnson
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OAB Treatment Market by Type
  3. 1.2.1 Global OAB Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Botox
  5. 1.2.3 Mirabegron
  6. 1.2.4 Anticholinergics
  7. 1.2.5 Others
  8. 1.3 OAB Treatment Market by Application
  9. 1.3.1 Global OAB Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Idiopathic Overactive Bladder
  11. 1.3.3 Neurogenic Overactive Bladder
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 OAB Treatment Market Dynamics
  1. 2.1 OAB Treatment Industry Trends
  2. 2.2 OAB Treatment Industry Drivers
  3. 2.3 OAB Treatment Industry Opportunities and Challenges
  4. 2.4 OAB Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global OAB Treatment Market Perspective (2021-2032)
  2. 3.2 Global OAB Treatment Growth Trends by Region
  3. 3.2.1 Global OAB Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OAB Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global OAB Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global OAB Treatment Revenue by Players
  2. 4.1.1 Global OAB Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global OAB Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global OAB Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OAB Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global OAB Treatment Key Players Headquarters & Area Served
  7. 4.4 Global OAB Treatment Players, Product Type & Application
  8. 4.5 Global OAB Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global OAB Treatment Market CR5 and HHI
  11. 4.6.3 2025 OAB Treatment Tier 1, Tier 2, and Tier 3
5 OAB Treatment Market Size by Type
  1. 5.1 Global OAB Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global OAB Treatment Revenue by Type (2021-2032)
  3. 5.3 Global OAB Treatment Revenue Market Share by Type (2021-2032)
6 OAB Treatment Market Size by Application
  1. 6.1 Global OAB Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global OAB Treatment Revenue by Application (2021-2032)
  3. 6.3 Global OAB Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Astellas Pharma
  2. 7.1.1 Astellas Pharma Company Information
  3. 7.1.2 Astellas Pharma Business Overview
  4. 7.1.3 Astellas Pharma OAB Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Astellas Pharma OAB Treatment Product Portfolio
  6. 7.1.5 Astellas Pharma Recent Developments
  7. 7.2 Kyorin Pharmaceutical
  8. 7.2.1 Kyorin Pharmaceutical Company Information
  9. 7.2.2 Kyorin Pharmaceutical Business Overview
  10. 7.2.3 Kyorin Pharmaceutical OAB Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Kyorin Pharmaceutical OAB Treatment Product Portfolio
  12. 7.2.5 Kyorin Pharmaceutical Recent Developments
  13. 7.3 AbbVie
  14. 7.3.1 AbbVie Company Information
  15. 7.3.2 AbbVie Business Overview
  16. 7.3.3 AbbVie OAB Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AbbVie OAB Treatment Product Portfolio
  18. 7.3.5 AbbVie Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer OAB Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer OAB Treatment Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson OAB Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson OAB Treatment Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
  31. 7.6 Teva
  32. 7.6.1 Teva Company Information
  33. 7.6.2 Teva Business Overview
  34. 7.6.3 Teva OAB Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Teva OAB Treatment Product Portfolio
  36. 7.6.5 Teva Recent Developments
8 North America
  1. 8.1 North America OAB Treatment Revenue (2021-2032)
  2. 8.2 North America OAB Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America OAB Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America OAB Treatment Revenue by Type (2027-2032)
  5. 8.3 North America OAB Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America OAB Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America OAB Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America OAB Treatment Revenue by Application (2027-2032)
  9. 8.5 North America OAB Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America OAB Treatment Revenue by Country
  11. 8.6.1 North America OAB Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America OAB Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America OAB Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe OAB Treatment Revenue (2021-2032)
  2. 9.2 Europe OAB Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe OAB Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe OAB Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe OAB Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe OAB Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe OAB Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe OAB Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe OAB Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe OAB Treatment Revenue by Country
  11. 9.6.1 Europe OAB Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe OAB Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe OAB Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China OAB Treatment Revenue (2021-2032)
  2. 10.2 China OAB Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China OAB Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China OAB Treatment Revenue by Type (2027-2032)
  5. 10.3 China OAB Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China OAB Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China OAB Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China OAB Treatment Revenue by Application (2027-2032)
  9. 10.5 China OAB Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OAB Treatment Revenue (2021-2032)
  2. 11.2 Asia OAB Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia OAB Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia OAB Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia OAB Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia OAB Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia OAB Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia OAB Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia OAB Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia OAB Treatment Revenue by Country
  11. 11.6.1 Asia OAB Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia OAB Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia OAB Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OAB Treatment Revenue (2021-2032)
  2. 12.2 SAMEA OAB Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA OAB Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA OAB Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA OAB Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA OAB Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA OAB Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA OAB Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA OAB Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA OAB Treatment Revenue by Country
  11. 12.6.1 SAMEA OAB Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA OAB Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA OAB Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst